SCHEMBL3119876

SCHEMBL3119876

Cc1cccc(Cc2cc3ccccc3cn2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.46
CYP2A6 P11509 1/20 0.46
PDE10A Q9Y233 3/20 0.43
FYN P06241 3/20 0.42
HTR2C P28335 1/20 0.42
HTR2B P41595 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
ATM Q13315 1/20 0.42
CYP2C19 P33261 2/20 0.40
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
KDM4E B2RXH2 1/20 0.40
PSMD14 O00487 1/20 0.40
LMNA P02545 1/20 0.40
HPGD P15428 1/20 0.40
AGTR1 P30556 1/20 0.40
OPRK1 P41145 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23715914 0.83 CYP1A2 (0.48) CYP1A2CYP2A6PDE10AHTR2BL3MBTL1
SCHEMBL21363719 0.83 CYP2A6 (0.50) CYP1A2CYP2A6PDE10AHTR2CHTR2B
SCHEMBL3121339 0.83 HTR2B (0.50) CYP1A2CYP2A6PDE10AHTR2BL3MBTL1
SCHEMBL3121450 0.81 HTR2C (0.42) PDE10AHTR2CHTR2BL3MBTL1ATM
SCHEMBL21951174 0.75 CYP1A2 (0.44) CYP1A2CYP2A6PDE10AHTR2BL3MBTL1
SCHEMBL3128182 0.75 PDE10A (0.52) CYP1A2CYP2A6PDE10AHTR2CHTR2B
SCHEMBL21142106 0.75 CYP2C19 (0.60) CYP1A2FYNL3MBTL1CYP2C19ALDH1A1
SCHEMBL30638836 0.75 CYP2C19 (0.60) CYP1A2FYNL3MBTL1CYP2C19ALDH1A1
SCHEMBL3129580 0.74 SLC6A2 (0.44) PDE10AL3MBTL1ATMCYP2C19ALDH1A1
SCHEMBL3116975 0.74 NPC1 (0.55) CYP1A2CYP2A6PDE10AFYNL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2143714-B1 TETRAHYDROISOQUINOLINE COMPOUND KOWA CO (JP) 2013-06-05 EP disclosed
EP-2143714-B1 TETRAHYDROISOQUINOLINE COMPOUND KOWA CO (JP) 2013-06-05 EP disclosed
US-8273766-B2 Tetrahydroisoquinoline compound KOWA COMPANY, LTD. (JP) 2012-09-25 US disclosed
US-8273766-B2 Tetrahydroisoquinoline compound KOWA COMPANY, LTD. (JP) 2012-09-25 US disclosed
US-8273766-B2 Tetrahydroisoquinoline compound KOWA COMPANY, LTD. (JP) 2012-09-25 US disclosed
US-20100120844-A1 TETRAHYDROISOQUINOLINE COMPOUND KOWA COMPANY, LTD. (JP) 2010-05-13 US disclosed
US-20100120844-A1 TETRAHYDROISOQUINOLINE COMPOUND KOWA COMPANY, LTD. (JP) 2010-05-13 US disclosed
US-20100120844-A1 TETRAHYDROISOQUINOLINE COMPOUND KOWA COMPANY, LTD. (JP) 2010-05-13 US disclosed
EP-2143714-A1 TETRAHYDROISOQUINOLINE COMPOUND Kowa Company, Ltd. (JP) 2010-01-13 EP disclosed
EP-2143714-A1 TETRAHYDROISOQUINOLINE COMPOUND Kowa Company, Ltd. (JP) 2010-01-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120844-A1 TETRAHYDROISOQUINOLINE COMPOUND CCR3, CCR5, CCR1 CYP1A2 2092/4885CYP2A6 2912/4885PDE10A 2363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.